AMANDA GILL: Open Payments
NPI 1598230245 · VICKSBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 36 payments from 18 companies in 2025. Trend: 2023 $483 · 2024 $407 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $159 |
| Lundbeck LLC | 3 | $66 |
| JAZZ PHARMACEUTICALS INC. | 2 | $48 |
| Gilead Sciences, Inc. | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Theratechnologies Inc. | 1 | $30 |
| Lilly USA, LLC | 2 | $29 |
| Novo Nordisk Inc | 2 | $28 |
| SERVIER PHARMACEUTICALS LLC | 1 | $20 |
Products named: VYEPTI, DALVANCE, EPIDIOLEX, EMBLAVEO, AVYCAZ, PIFELTRO, FRUZAQLA, EGRIFTA.
Industry payments across MS — which companies pay providers there.
